CD8A and neoplasm: In contrast, ICOS monotherapy and ICOS/PD-1 combination group exhibited higher and more homogeneously-distributed CD8+ T-cell tumor infiltration as reflected by a higher IHC scoring in the core relative to the IgG controls (Table1).